These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 3740864

  • 1. [Production of a cytotoxic factor into malignant pleural fluid by OK-423, a streptococcal preparation--kinetic analysis].
    Yoshinaga T, Nomura H, Nishimura H, Tomino S, Kawakita M, Takatsuki K, Fujimoto K, Etou Y, Nakaji T, Kiyama T.
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2675-7. PubMed ID: 3740864
    [No Abstract] [Full Text] [Related]

  • 2. [Induction of the human tumor necrosis factor (h-TNF) by the streptococcal preparation, OK-432--a clinical trial in 10 lung cancer patients with pleural fluid].
    Miyai M, Matsuka Y, Tsubota T, Asano K.
    Nihon Gan Chiryo Gakkai Shi; 1986 Jul 20; 21(6):1285-91. PubMed ID: 3782979
    [No Abstract] [Full Text] [Related]

  • 3. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
    Kokunai I, Shimano T, Sekimoto K, Takeda T, Kobayashi T, Yayoi E, Yamamoto A, Mori T.
    J Clin Lab Immunol; 1986 Dec 20; 21(4):169-71. PubMed ID: 3560194
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1 inducing activity of a streptococcal preparation OK-432 and its fractions by human monocytes.
    Katsuta S, Kaneko Y, Tsutsui K, Tamaki S, Ibata H, Chen DR, Suzuki S, Natsuume-Sakai S, Yamamoto A.
    J Clin Lab Immunol; 1989 Mar 20; 28(3):129-36. PubMed ID: 2661826
    [Abstract] [Full Text] [Related]

  • 5. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
    Kaneto E, Sasaki H, Tamura I, Kurimura O, Kurimura T.
    Biken J; 1983 Jun 20; 26(2):99-102. PubMed ID: 6318725
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432.
    Watabe S, Sendo F, Kimura S, Arai S.
    J Natl Cancer Inst; 1984 Jun 20; 72(6):1365-70. PubMed ID: 6587156
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
    Kimura Y, Toki H, Okabe K, Fujii M, Tamai M.
    Gan To Kagaku Ryoho; 1986 Jan 20; 13(1):95-100. PubMed ID: 3942400
    [Abstract] [Full Text] [Related]

  • 10. [In vivo augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432: characterization of effector cells and induction of interferon in sera (author's transl)].
    Wakasugi H, Miyata M, Morioka Y, Oshimi K, Kasahara T, Takahashi K, Saito M, Ebina T.
    Nihon Gan Chiryo Gakkai Shi; 1981 Jun 20; 16(3):433-46. PubMed ID: 7320603
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K, Kano S, Takaku F, Okumura K.
    J Natl Cancer Inst; 1980 Dec 20; 65(6):1265-9. PubMed ID: 7001124
    [Abstract] [Full Text] [Related]

  • 13. [Partial response of lung metastases from a renal cancer treated with endogenous tumor necrosis factor].
    Kato M, Ishiwata D, Kakehi R, Oshima N, Soma G, Mizuno D.
    Gan To Kagaku Ryoho; 1987 Jul 20; 14(7):2378-80. PubMed ID: 3606157
    [Abstract] [Full Text] [Related]

  • 14. [Induction of tumor necrosis factor (TNF) by OK-432].
    Watanabe N, Sone H, Neda H, Niitsu Y, Urushizaki I.
    Gan No Rinsho; 1984 Aug 20; 30(10):1290-2. PubMed ID: 6481965
    [Abstract] [Full Text] [Related]

  • 15. [Definition of tumor-necrosis factor and its production mechanism].
    Urushizaki I, Niitsu Y, Watanabe N.
    Gan To Kagaku Ryoho; 1984 Jul 20; 11(7):1356-68. PubMed ID: 6378100
    [Abstract] [Full Text] [Related]

  • 16. Detection of tumour necrosis factor/cachectin in pleural effusion of patients with lung cancer.
    Ishii Y, Uchiyama Y, Hasegawa S, Kinoshita T, Mitsui K, Kojima H, Fujita T.
    Clin Exp Immunol; 1990 Jun 20; 80(3):350-3. PubMed ID: 2372984
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T, Takahashi N, Terakado M, Sato M, Sugane T, Kisohara A, Akusawa H, Tsujino I, Horie T.
    Gan To Kagaku Ryoho; 2005 Aug 20; 32(8):1139-43. PubMed ID: 16121916
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients.
    Prado-Garcia H, Aguilar-Cazares D, Flores-Vergara H, Mandoki JJ, Lopez-Gonzalez JS.
    Lung Cancer; 2005 Mar 20; 47(3):361-71. PubMed ID: 15713519
    [Abstract] [Full Text] [Related]

  • 20. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
    Ogushi F, Fukuoka M, Takada M, Tamai S, Sakai N, Negoro S, Okunaka N, Sone S, Tsubura E.
    Jpn J Clin Oncol; 1984 Sep 20; 14(3):321-7. PubMed ID: 6090732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.